In mice bearing xenografted MCF-7 breast tumors, a PEG-conjugated anti-CSF-1 Fab was reported to have therapeutic effect, reducing macrophage recruitment to the tumor and reversing tumor resistance to combined chemotherapy [48]. The gene discussed is CSF1; the disease is neoplasm.